These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32274748)

  • 1. Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy.
    Ni Y; Qin Y; Huang Z; Liu F; Zhang S; Zhang Z
    Adv Ther; 2020 May; 37(5):2550-2559. PubMed ID: 32274748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD
    PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in proliferative vitreoretinopathy.
    El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M
    Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.
    El-Ghrably IA; Dua HS; Orr GM; Fischer D; Tighe PJ
    Br J Ophthalmol; 2001 Apr; 85(4):461-70. PubMed ID: 11264138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.